Medical News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

4150 of 112955
Newswise: Roswell Park Moving Unique Immunotherapy Platform Forward With $6.42 Million DoD Grant

Article ID: 719179

Roswell Park Moving Unique Immunotherapy Platform Forward With $6.42 Million DoD Grant

Roswell Park Comprehensive Cancer Center

A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a DoD grant that will fund a clinical trial in patients with brain-metastatic breast cancer.

Released:
18-Sep-2019 10:40 AM EDT
Academy-dual-blue3005.jpg

Article ID: 719182

Wisconsin Physicians Honored for Cross-Specialty Collaboration to Advance Skin Cancer Treatment

American Academy of Dermatology

The American Academy of Dermatology has honored dermatologist Gloria Xu, MD, PhD, FAAD, and oncologist Mark Albertini, MD, as Patient Care Heroes for their leadership in launching a melanoma tumor board to optimize care for melanoma patients at the University of Wisconsin School of Medicine and Public Health.

Released:
18-Sep-2019 10:40 AM EDT
Embargo will expire:
20-Sep-2019 5:00 AM EDT
Released to reporters:
18-Sep-2019 10:35 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Sep-2019 5:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Tulane University student spends summer conducting brain tumor research in Switzerland

Article ID: 719173

Tulane University student spends summer conducting brain tumor research in Switzerland

Tulane University

Tulane University senior James Rogers has been charting a course in the name of research since he arrived on campus in the fall of 2016. Rogers’ journey has led him from New Orleans to Bethesda, Md., across the Atlantic to Scotland and, most recently, Switzerland, where he spent the summer as a visiting research scholar in the Brain Tumor Center at the University Hospital Zürich (USZ).

Released:
18-Sep-2019 10:30 AM EDT
Newswise: U.S. Comptroller Appoints Chiropractor Christine Goertz as Chair of PCORI Board

Article ID: 719186

U.S. Comptroller Appoints Chiropractor Christine Goertz as Chair of PCORI Board

American Chiropractic Association

The American Chiropractic Association (ACA) is pleased to announce that ACA Senior Scientific Advisor Christine Goertz, DC, PhD, has been appointed by the Comptroller of the United States to a three-year term as chair of the Patient-Centered Outcomes Research Institute (PCORI) Board of Governors.

Released:
18-Sep-2019 10:05 AM EDT
Embargo will expire:
20-Sep-2019 12:00 AM EDT
Released to reporters:
18-Sep-2019 10:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Sep-2019 12:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Social and Behavioral Sciences

Newswise: MicroRNA-based Therapy May be New Weapon to Combat Cancer

Article ID: 719166

MicroRNA-based Therapy May be New Weapon to Combat Cancer

Stony Brook University

A technology that manipulates microRNAs (miRNAs) developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.

Released:
18-Sep-2019 9:05 AM EDT

Feature

Channels:

Cancer, Pharmaceuticals

Languages:

English

Newswise: Johns Hopkins Researchers ID Compound That Could Play A Novel Role In Halting Pancreatic Cancer Progression

Article ID: 719106

Johns Hopkins Researchers ID Compound That Could Play A Novel Role In Halting Pancreatic Cancer Progression

Johns Hopkins Medicine

In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.

Released:
18-Sep-2019 9:00 AM EDT
chp-logo.jpg

Article ID: 719118

Brain Imaging Shows How Minimally Verbal and Nonverbal Children with Autism Have Slower Response to Sounds

Children's Hospital of Philadelphia

Researchers at Children’s Hospital of Philadelphia (CHOP)used state-of-the-art brain imaging techniques to determine how nonverbal or minimally verbal children who have autism spectrum disorder (ASD) processes auditory stimuli, which could have important diagnostic and prognostic implications across the autism spectrum.

Released:
18-Sep-2019 9:00 AM EDT

Showing results

4150 of 112955

Chat now!